# Invesco S&P World Health Care ESG UCITS ETF Accum USD (WHCG)

**Page:** https://fundology.uk/fund/whcg · ISIN IE000L4EH2K5

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 20/11/2026, WHCG (Invesco S&P World Health Care ESG UCITS ETF Accum USD, ISIN IE000L4EH2K5) closed at £5.64 on the London Stock Exchange. Its ongoing charge is 0.18% a year (about £18 on £10,000). Over the three years to 20/11/2026 its total return was +23.8%, or +11.5% after UK CPIH inflation.

## Summary

Invesco S&P World Health Care ESG UCITS ETF Accum USD is an exchange-traded fund (ETF) from Invesco, launched in 2023. It tracks the S&P World ESG Enhanced Health Care Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.18% a year — about £18 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£5.64** (20/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | WHCG |
| ISIN | IE000L4EH2K5 |
| Also listed as | WHCE (London Stock Exchange, US dollars), WH2E (Xetra, euros) |
| Category | Healthcare |
| Type | ETF |
| Provider | Invesco |
| Tracks | S&P World ESG Enhanced Health Care Index |
| Income | Accumulating |
| Ongoing charge | 0.18% a year (£18 per £10,000) |
| Fund size | £15.4m |
| Launched | 2023 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 12/04/2023 |

## Past returns (periods to 20/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +14.62% | +10.58% | income reinvested |
| 3 years | +23.79% | +11.46% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund): 2024 +4.9%, 2025 +5.6%; 2026 to 19/11/2026 +15.5%. Returns of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +13.6%; to 30/09/2025: −4.7%; to 30/09/2024: +11.5%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2024 | +4.9% | +1.3% | Price |
| 2025 | +5.6% | +1.9% | Price |
| 2026 to 19/11/2026 | +15.5% | +11.4% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 18.10% | -12.81% |
| 3 years | 15.50% | -19.96% |

## Largest fall

Volatility of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds, annualised from weekly returns to 19/11/2026: 18.1% over 1 year, 15.5% over 3 years. Largest fall in the price of Invesco S&P World Health Care ESG UCITS ETF Accum USD since April 2023, in pounds: −20.0% from 30/08/2024 to 23/05/2025. The lowest 12-month return of Invesco S&P World Health Care ESG UCITS ETF Accum USD in pounds (price, with income reinvested in the fund) since April 2023 was −17.1% (12 months to 08/08/2025); the highest was +24.9% (12 months to 30/10/2026). On 19/11/2026 the price of Invesco S&P World Health Care ESG UCITS ETF Accum USD was 3.7% below its highest weekly close since April 2023 (13/11/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Invesco S&P World Health Care ESG UCITS ETF Accum USD 0.18% a year. Compared on 20/11/2026, 21 of the 28 other healthcare funds charge more, 3 the same and 4 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.18%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 12/11/2026, WHCG holds 66 positions, according to its published holdings. The largest is Eli Lilly at 17.96% of the fund; the ten largest make up 65.1%.

### Top holdings

Largest positions (as of 12/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Eli Lilly | [LLY](https://fundology.uk/stock/LLY) | 17.96% |
| 2 | AbbVie | [ABBV](https://fundology.uk/stock/ABBV) | 10.74% |
| 3 | Merck | [MRK](https://fundology.uk/stock/MRK) | 6.12% |
| 4 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 5.09% |
| 5 | Gilead Sciences | [GILD](https://fundology.uk/stock/GILD) | 4.66% |
| 6 | Roche | [RO](https://fundology.uk/stock/RO) | 4.48% |
| 7 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 4.37% |
| 8 | Amgen | [AMGN](https://fundology.uk/stock/AMGN) | 4.23% |
| 9 | Thermo Fisher Scientific | [TMO](https://fundology.uk/stock/TMO) | 4.20% |
| 10 | Abbott Laboratories | [ABT](https://fundology.uk/stock/ABT) | 3.27% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By country

Added up from the fund’s published holdings, as of 12/11/2026.

| Country | Weight |
|---|---|
| United States | 68.8% |
| Switzerland | 10.2% |
| United Kingdom | 5.9% |
| Japan | 4.2% |
| Ireland | 2.3% |
| France | 2.1% |
| Denmark | 1.4% |
| Australia | 1.2% |
| Other countries | 3.8% |

All 66 holdings: https://fundology.uk/fund/whcg/holdings

## Questions people ask

**What is the ongoing charge of WHCG?**

The ongoing charge of WHCG is 0.18% a year — about £18 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco S&P World Health Care ESG UCITS ETF Accum USD 0.18% a year. Compared on 20/11/2026, 21 of the 28 other healthcare funds charge more, 3 the same and 4 less (share classes counted once).

**What does WHCG track?**

WHCG tracks the S&P World ESG Enhanced Health Care Index.

**Is WHCG accumulating or distributing?**

WHCG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of WHCG?**

The ISIN of WHCG is IE000L4EH2K5. An ISIN identifies one exact share class of a fund; WHCG is its ticker on the London Stock Exchange. The same share class is also listed as WHCE (London Stock Exchange, US dollars) and WH2E (Xetra, euros).

**What does WHCG hold?**

As of 12/11/2026, WHCG holds 66 positions, according to its published holdings. The largest is Eli Lilly at 17.96% of the fund; the ten largest make up 65.1%. Its ten largest holdings are Eli Lilly (17.96%), AbbVie (10.74%), Merck (6.12%), AstraZeneca (5.09%), Gilead Sciences (4.66%), Roche (4.48%), Novartis (4.37%), Amgen (4.23%), Thermo Fisher Scientific (4.20%) and Abbott Laboratories (3.27%).

**What were WHCG’s returns in each of the last five years?**

Calendar-year returns of WHCG in pounds (price, with income reinvested in the fund): 2024 +4.9%, 2025 +5.6%; 2026 to 19/11/2026 +15.5%. Past performance is not a guide to future returns.

**How has WHCG done after inflation?**

Over the three years to 20/11/2026 WHCG’s total return was +23.8%, or +11.5% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.
